Cortisol, 11 -hydroxysteroid dehydrogenase type 1 and central obesity

Author： Stewart P.M.   Tomlinson J.W.  

Publisher： Elsevier

E-ISSN： 1879-3061|13|3|94-96

ISSN： 1043-2760

Source： Trends in Endocrinology and Metabolism, Vol.13, Iss.3, 2002-04, pp. : 94-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

11β-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes

By Stulnig T.   Waldhäusl W.  

Diabetologia, Vol. 47, Iss. 1, 2004-01 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of 11β-hydroxysteroid dehydrogenase type 1 in obesity

By Wake Deborah   Walker Brian  

Endocrine Journal, Vol. 29, Iss. 1, 2006-02 ,pp. : 101-108

Humana Press, Inc

Access to resources Recommend Favorite

Ovarian modulators of type 1 11‐hydroxysteroid dehydrogenase (11HSD) activity and intra‐follicular cortisol:cortisone ratios correlate with the clinical outcome of IVF

By Thurston L.M.  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1603-1612

Oxford University Press

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle

By Nair S.   Lee Y.   Lindsay R.   Walker B.   Tataranni P.   Bogardus C.   Baier L.   Permana P.  

Diabetologia, Vol. 47, Iss. 6, 2004-06 ,pp. : 1088-1095

Springer Publishing Company

Access to resources Recommend Favorite

The Hypertensiogenetic Steroid 19-nor-Progesterone does not Influence Cortisol Inactivation by 11β-Hydroxysteroid Dehydrogenase Type 2

By Lepenies Julia   Stewart Paul   Quinkler Marcus  

Clinical and Experimental Hypertension, Vol. 31, Iss. 4, 2009-07 ,pp. : 376-379

Informa Healthcare

Access to resources Recommend Favorite